Ephrin A4 expression in osteosarcoma, impact on prognosis, and patient outcome

Indian Journal of Cancer

Volumn 47, Issue 1, 2010, Pages 46-52

  Abdou, A G ^a   Abd El Wahed, M M ^a   Asaad, N Y ^a   Samaka, R M ^a   Abdallaha, R ^a  

^a MENOUFIA UNIVERSITY   (Egypt)

Author keywords

Ephrin A4; Osteosarcoma; Prognosis; Response to chemotherapy

Indexed keywords

EPHRIN A4;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; EVENT FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; OSTEOSARCOMA; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; EPHRIN-A4; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM STAGING; OSTEOSARCOMA; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 75749084044     PISSN: 0019509X     EISSN: 19984774     Source Type: Journal    
DOI: 10.4103/0019-509X.58859     Document Type: Article

References (22)

1. Rosenberg AE, Kumar V, Abbas AK, Fausto N. Bones, joints, and soft tissue tumors. Robbins and Cotran pathological basis of disease. 7th edition Ch 26; 2004. p. 1273-1324.
2. El-Bolkainy M, Nouh A, El-Bolkainy T. Bone sarcomas. In El-Bolkainy Topographic Pathology of Cancer: third edition, NCI, Cairo University 2005;12:105-114
3. Mokhtar N, Gouda I, Adel I. Malignant bone tumors. editors: Cancer pathology registry 2003-2004 and timed trend analysis. 1st edition. Cairo: NCI, Elsheraa Press 2007;11:88-89
4. Jubb AM, Zhong F, Bheddah S, Grabsch HI, Frantz GD, Mueller W, et al. EphB2 is a prognostic factor in colorectal cancer. Clin Cancer Res 2005;11:5181-5187
5. Kozlosky CJ, Maraskovsky E, McGrew JT, VandenBos T, Teepe M, Lyman SD, et al. Ligands for the receptor tyrosine kinases hek and elk: isolation of cDNAs encoding a family of proteins. Oncogene. 1995;10:299-306
6. Surawska H, Ma PC, Salgia R. The role of ephrins and Eph receptors in cancer. Cytokine Growth Factor Rev 2004;15:419-433
7. Abdou AG, Abd El-Wahed MM, Asaad NY, Samaka RM, Abdallaha R. Immunohistochemical profile of ephrin A4 expression in human osteosarcoma. APMIS 2009;117:277-285
8. Bacci G, Longhi A, Versari M, Mercuri M, Briccoli A, Picci P. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer 2006;106:1154-1161 (Pubitemid 43297356)
9. Neff J, Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE, Kastan MB, McKenna WG, eds. Sarcomas of bone. Clinical Oncology, Philadelphia, Elsevier; 2004. P. 2471-2572
10. Giri DK, Ali-Seyed M, Li LY, Lee DF, Ling P, Bartholomeusz G, et al. Endosomal transport of ErbB-2: mechanism for nuclear entry of the cell surface receptor. Mol Cell Biol 2005;25:11005-11018
11. Varelias A, Koblar SA, Cowled PA, Carter CD, Clayer M. Human osteosarcoma expresses specific ephrin profiles: implications for tumorigenicity and prognosis. Cancer. 2002;95:862-869
12. Berclaz G, Flütsch B, Altermatt HJ, Rohrbach V, Djonov V, Ziemiecki A, et al. Loss of EphB4 receptor tyrosine kinase protein expression during carcinogenesis of the human breast. Oncol Rep 2002;9:985-989
13. Maran A. Estrogen Metabolites in the Control of Osteosarcoma. Cell science 2005;2:1742-8130.
14. McHugh JB, Thomas DG, Herman JM, Ray ME, Baker LH, Adsay NV, et al. Primary versus radiation-associated craniofacial osteosarcoma: Biologic and clinicopathologic comparisons. Cancer 2006;107:554-562
15. Abraham S, Knapp DW, Cheng L, Snyder PW, Mittal SK, Bangari DS, et al. Expression of EphA2 and Ephrin A-1 in Carcinoma of the Urinary Bladder. Clin Cancer Res 2006;12:353-360
16. Easty DJ, Hill SP, Hsu MY, Fallowfield ME, Florenes VA, Herlyn M, et al. Up-regulation of ephrin-A1 during melanoma progression. Int J Cancer 1999;84:494-501.
17. Lin YG, Han LY, Kamat AA, Merritt WM, Landen CN, Deavers MT, et al. EphA2 overexpression is associated with angiogenesis in ovarian cancer. Cancer 2007;109:332-340
18. Herath NI, Spanevello MD, Sabesan S, Newton T, Cummings M, Duffy S, et al. Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival. BMC Cancer 2006;6:144.
19. Bacci G, Bertoni F, Longhi A, Ferrari S, Forni C, Biagini R, et al. Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor. Cancer 2003;97:3086-3175
20. Wu D, Suo Z, Kristensen GB, Li S, Troen G, Holm R, Nesland JM. Prognostic Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma. Gynecol Oncol 2004;94:312-319 (Pubitemid 39024532)
21. Castellvi J, Garcia A, de la Torre J, Hernandez J, Gil A, Xercavins J, et al. Ephrin B expression in epithelial ovarian neoplasms correlates with tumor differentiation and angiogenesis. Hum Pathol 2006;37:883-889
22. Kumar SR, Singh J, Xia G, Krasnoperov V, Hassanieh L, Ley EJ, et al. Receptor tyrosine kinase EphB4 is a survival factor in breast cancer. Am J Pathol 2006;169:279-293